Abstract
The occurrence of macular edema as an adverse effect of fingolimod is well documented. Treatment modalities used to manage fingolimod-associated macular edema (FAME) have included nonsteroidal anti-inflammatory agents and sub-tenon injection. We describe two cases where intravitreal injection is used to successfully treat FAME in patients who were previously unsuccessfully treated with topical nonsteroidal anti-inflammatories.
| Original language | English |
|---|---|
| Pages (from-to) | 249-251 |
| Number of pages | 3 |
| Journal | Multiple Sclerosis |
| Volume | 21 |
| Issue number | 2 |
| DOIs | |
| Publication status | Published - 17 Feb 2015 |
Keywords
- Edema
- Fingolimod
- Multiple sclerosis
- Steroid